Resistant arterial hypertension and hyperlipidemia: Atorvastatin, not vitamin C, for blood pressure control

Israel Medical Association Journal

Volumn 6, Issue 12, 2004, Pages 742-746

  Magen, Eli ^a,c   Viskoper, Reuven ^a,c   Mishal, Joseph ^a,c   Priluk, Rita ^a,c   Berezovsky, Arkadi ^a,c   Laszt, Anni ^a,c   London, Daniel ^a,c   Yosefy, Chaim ^b  

^a BARZILAI MEDICAL CENTER   (Israel)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Endothelial function; Resistant hypertension; Statins; Vitamin C

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; ASCORBIC ACID; ATENOLOL; ATORVASTATIN; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CILAZAPRIL; CLONIDINE; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL; FOSINOPRIL; HYDROCHLOROTHIAZIDE; LERCANIDIPINE; LOSARTAN; LOW DENSITY LIPOPROTEIN; METOPROLOL; NIFEDIPINE; PENEDIL; PLACEBO; PROPRANOLOL; RAMIPRIL; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; DOSE RESPONSE; DRUG EFFICACY; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MALE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTOLIC BLOOD PRESSURE;

ANTICHOLESTEREMIC AGENTS; ANTIHYPERTENSIVE AGENTS; ASCORBIC ACID; BLOOD PRESSURE; BRACHIAL ARTERY; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; PYRROLES;

EID: 10644237083     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Alper AB Jr, Calhoun DA. Contemporary management of refractory hypertension. Curr Hypertens Rep 1999;1(5):402-7.
2. Townsend RR. Refractory or resistant hypertension. J Clin Hypertens 2002;4(1):61.
3. Martell N, Rodriguez-Cerrillo M, Grobbee DE, et al. High prevalence of secondary hypertension and insulin resistance in patients with refractory hypertension. Blood Press 2003;12(3):149-54.
4. Ouzan J, Perault C, Lincoff AM, Carre E, Mertes M. The role of spironolactone in the treatment of patients with refractory hypertension. Am J Hypertens 2002;15(4 Pt 1):333-9.
5. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997;95:1126-31.
6. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
7. Wilson TW, Alonso Galicia M, Roman RJ. Effects of lipid-lowering agents in the Dahl salt-sensitive rat. Hypertension 1998;31:225-31.
8. Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet 1999;ii:2048-9.
9. Ettarh RR, Odigie IP, Adigun SA. Vitamin C lowers blood pressure and alters vascular responsiveness in salt-induced hypertension. Can J Physiol Pharmacol 2002;80(12):1199-202.
10. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194-202.
11. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336:1117-24.
12. Sherman DL, Keaney JF Jr, Biegelsen ES, Duffy SJ, Coffman JD, Vita JA. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000;35:936-41.
13. Corretti MC, Anderson TJ, Benjamin EJ, et al., for the International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002 20;39(6):1082.
14. Sung BH, Izzo, JL Jr, Wilson MF. Effects of cholesterol reduction on BP response to mental stress in patients with high cholesterol. Am J Hypertens 1997;10:592-9.
15. Straznicky NE, Howes LG, Lam W, Louis WJ. Effects of pravastatin on cardiovascular reactivity to norepinephrine and angiotensin II in patients with hypercholesterolemia and systemic hypertension. Am J Cardiol 1995;75:582-6.
16. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998;97:2222-9.
17. Ortego M, Bustos C, Hernandez-Prosa MA, et al. Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 1999;147:253-61.
18. Bautista LE. Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence. J Hum Hypertens 2003;17(4):223-30.
19. Virdis A, Schiffrin EL. Vascular inflammation: a role in vascular disease in hypertension? Curr Opin Nephrol Hypertens 2003;12(2):181-7.
20. Russo C, Olivieri O, Girelli D, et al. Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998;16(9):1267-71.
21. Hajjar IM, George V, Sasse EA, Kochar MS. A randomized, double-blind, controlled trial of vitamin C in the management of hypertension and lipids. Am J Ther 2002;9(4):289-93.
22. On YK, Kim CH, Sohn DW, et al. Improvement of endothelial function by amlodipine and vitamin C in essential hypertension. Korean J Intern Med 2002:17(2):131-7.
23. Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension 2002;40(6):797-803.
24. Darko D, Dornhorst A, Kelly FJ, Ritter JM, Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in Type II diabetes. Clin Sci 2002;103(4):339-44.